Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: AMGEN CANADA INC
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02459299 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 50 MG / ML |
| Marketed | 02459299 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Prescription | 1 | ADALIMUMAB | 50 MG / ML |
| Marketed | 02459302 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 50 MG / ML |
| Marketed | 02459302 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Prescription | 1 | ADALIMUMAB | 50 MG / ML |
| Marketed | 02459310 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Prescription | 1 | ADALIMUMAB | 50 MG / ML |
| Marketed | 02459310 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 50 MG / ML |
| Approved | 02246353 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 15 MCG / ML |
| Approved | 02246353 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 15 MCG / ML |
| Cancelled Post Market | 02246354 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 25 MCG / ML |
| Cancelled Post Market | 02246354 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 25 MCG / ML |
| Approved | 02246356 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 60 MCG / ML |
| Approved | 02246356 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 60 MCG / ML |
| Approved | 02246359 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 325 MCG / ML |
| Approved | 02246359 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 325 MCG / ML |
| Approved | 02391732 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
| Approved | 02391732 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
| Marketed | 02391740 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 100 MCG / ML |
| Marketed | 02391740 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 100 MCG / ML |
| Marketed | 02391759 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 100 MCG / ML |
| Marketed | 02391759 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 100 MCG / ML |
| Marketed | 02391767 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Marketed | 02391767 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Marketed | 02391775 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Marketed | 02391775 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Marketed | 02391783 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Marketed | 02391783 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Marketed | 02391791 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Marketed | 02391791 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Marketed | 02391805 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Marketed | 02391805 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Approved | 02391813 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Approved | 02391813 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Marketed | 02391821 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Marketed | 02391821 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Approved | 02391848 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Approved | 02391848 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Marketed | 02392313 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 25 MCG / ML |
| Marketed | 02392313 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 25 MCG / ML |
| Marketed | 02392321 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
| Marketed | 02392321 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
| Marketed | 02392348 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 100 MCG / ML |
| Marketed | 02392348 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 100 MCG / ML |
| Marketed | 02392356 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Marketed | 02392356 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Marketed | 02392364 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Marketed | 02392364 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Cancelled Post Market | 02246355 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
| Cancelled Post Market | 02246355 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
| Cancelled Post Market | 02246357 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 100 MCG / ML |
| Cancelled Post Market | 02246357 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 100 MCG / ML |
| Cancelled Post Market | 02246358 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Cancelled Post Market | 02246358 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 200 MCG / ML |
| Cancelled Post Market | 02246360 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Cancelled Post Market | 02246360 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 500 MCG / ML |
| Marketed | 02496933 | AMGEN CANADA INC | AVSOLA | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
| Marketed | 02496933 | AMGEN CANADA INC | AVSOLA | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
| Marketed | 02450283 | AMGEN CANADA INC | BLINCYTO | Human | Yes | Schedule D | 1 | BLINATUMOMAB | 38.5 MCG / VIAL |
| Marketed | 02450283 | AMGEN CANADA INC | BLINCYTO | Human | Yes | Prescription | 1 | BLINATUMOMAB | 38.5 MCG / VIAL |
| Marketed | 02489597 | AMGEN CANADA INC | EVENITY | Human | Yes | Prescription | 1 | ROMOSOZUMAB | 105 MG / 1.17 ML |
| Marketed | 02489597 | AMGEN CANADA INC | EVENITY | Human | Yes | Schedule D | 1 | ROMOSOZUMAB | 105 MG / 1.17 ML |
| Marketed | 02496690 | AMGEN CANADA INC | KANJINTI | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 420 MG / VIAL |
| Marketed | 02496690 | AMGEN CANADA INC | KANJINTI | Human | Yes | Prescription | 1 | TRASTUZUMAB | 420 MG / VIAL |
| Marketed | 02518244 | AMGEN CANADA INC | KANJINTI | Human | Yes | Prescription | 1 | TRASTUZUMAB | 150 MG / VIAL |
| Marketed | 02518244 | AMGEN CANADA INC | KANJINTI | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 150 MG / VIAL |
| Marketed | 02451034 | AMGEN CANADA INC | KYPROLIS | Human | Yes | Prescription | 1 | CARFILZOMIB | 60 MG / VIAL |
| Marketed | 02459930 | AMGEN CANADA INC | KYPROLIS | Human | Yes | Prescription | 1 | CARFILZOMIB | 10 MG / VIAL |
| Marketed | 02459949 | AMGEN CANADA INC | KYPROLIS | Human | Yes | Prescription | 1 | CARFILZOMIB | 30 MG / VIAL |
| Marketed | 02520095 | AMGEN CANADA INC | LUMAKRAS | Human | Yes | Prescription | 1 | SOTORASIB | 120 MG |
| Marketed | 02470748 | AMGEN CANADA INC | MVASI | Human | Yes | Prescription | 1 | BEVACIZUMAB | 25 MG / ML |
| Marketed | 02470748 | AMGEN CANADA INC | MVASI | Human | Yes | Schedule D | 1 | BEVACIZUMAB | 25 MG / ML |
| Marketed | 02470756 | AMGEN CANADA INC | MVASI | Human | Yes | Prescription | 1 | BEVACIZUMAB | 25 MG / ML |
| Marketed | 02470756 | AMGEN CANADA INC | MVASI | Human | Yes | Schedule D | 1 | BEVACIZUMAB | 25 MG / ML |
| Marketed | 02249790 | AMGEN CANADA INC | NEULASTA | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 10 MG / ML |
| Marketed | 02249790 | AMGEN CANADA INC | NEULASTA | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 10 MG / ML |
| Marketed | 01968017 | AMGEN CANADA INC | NEUPOGEN | Human | Yes | Schedule D | 1 | FILGRASTIM | 300 MCG / ML |
| Marketed | 01968017 | AMGEN CANADA INC | NEUPOGEN | Human | Yes | Prescription | 1 | FILGRASTIM | 300 MCG / ML |
| Marketed | 02420104 | AMGEN CANADA INC | NEUPOGEN | Human | Yes | Schedule D | 1 | FILGRASTIM | 600 MCG / ML |
| Marketed | 02420104 | AMGEN CANADA INC | NEUPOGEN | Human | Yes | Prescription | 1 | FILGRASTIM | 600 MCG / ML |
| Marketed | 02420112 | AMGEN CANADA INC | NEUPOGEN | Human | Yes | Schedule D | 1 | FILGRASTIM | 600 MCG / ML |
| Marketed | 02420112 | AMGEN CANADA INC | NEUPOGEN | Human | Yes | Prescription | 1 | FILGRASTIM | 600 MCG / ML |
| Marketed | 02322854 | AMGEN CANADA INC | NPLATE | Human | Yes | Prescription | 1 | ROMIPLOSTIM | 250 MCG / VIAL |
| Marketed | 02322854 | AMGEN CANADA INC | NPLATE | Human | Yes | Schedule D | 1 | ROMIPLOSTIM | 250 MCG / VIAL |
| Marketed | 02322862 | AMGEN CANADA INC | NPLATE | Human | Yes | Prescription | 1 | ROMIPLOSTIM | 500 MCG / VIAL |
| Marketed | 02322862 | AMGEN CANADA INC | NPLATE | Human | Yes | Schedule D | 1 | ROMIPLOSTIM | 500 MCG / VIAL |
| Marketed | 02434318 | AMGEN CANADA INC | OTEZLA | Human | Yes | Prescription | 3 | APREMILAST | 10 MG |
| Marketed | 02434334 | AMGEN CANADA INC | OTEZLA | Human | Yes | Prescription | 1 | APREMILAST | 30 MG |
| Marketed | 02343541 | AMGEN CANADA INC | PROLIA | Human | Yes | Prescription | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02343541 | AMGEN CANADA INC | PROLIA | Human | Yes | Schedule D | 1 | DENOSUMAB | 60 MG / ML |
| Cancelled Pre Market | 02343568 | AMGEN CANADA INC | PROLIA | Human | Yes | Prescription | 1 | DENOSUMAB | 60 MG / ML |
| Cancelled Pre Market | 02343568 | AMGEN CANADA INC | PROLIA | Human | Yes | Schedule D | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02446057 | AMGEN CANADA INC | REPATHA | Human | Yes | Schedule D | 1 | EVOLOCUMAB | 140 MG / ML |
| Marketed | 02446057 | AMGEN CANADA INC | REPATHA | Human | Yes | Prescription | 1 | EVOLOCUMAB | 140 MG / ML |
| Marketed | 02459779 | AMGEN CANADA INC | REPATHA | Human | Yes | Prescription | 1 | EVOLOCUMAB | 120 MG / ML |
| Marketed | 02459779 | AMGEN CANADA INC | REPATHA | Human | Yes | Schedule D | 1 | EVOLOCUMAB | 120 MG / ML |
| Dormant | 02513447 | AMGEN CANADA INC | RIABNI | Human | Yes | Prescription | 1 | RITUXIMAB | 10 MG / ML |
| Dormant | 02513447 | AMGEN CANADA INC | RIABNI | Human | Yes | Schedule D | 1 | RITUXIMAB | 10 MG / ML |
| Marketed | 02257130 | AMGEN CANADA INC | SENSIPAR | Human | Yes | Prescription | 1 | CINACALCET (CINACALCET HYDROCHLORIDE) | 30 MG |
| Marketed | 02257149 | AMGEN CANADA INC | SENSIPAR | Human | Yes | Prescription | 1 | CINACALCET (CINACALCET HYDROCHLORIDE) | 60 MG |
| Marketed | 02257157 | AMGEN CANADA INC | SENSIPAR | Human | Yes | Prescription | 1 | CINACALCET (CINACALCET HYDROCHLORIDE) | 90 MG |
| Marketed | 02308487 | AMGEN CANADA INC | VECTIBIX | Human | Yes | Prescription | 1 | PANITUMUMAB | 100 MG / 5 ML |
| Marketed | 02308487 | AMGEN CANADA INC | VECTIBIX | Human | Yes | Schedule D | 1 | PANITUMUMAB | 100 MG / 5 ML |
| Approved | 02308495 | AMGEN CANADA INC | VECTIBIX | Human | Yes | Prescription | 1 | PANITUMUMAB | 200 MG / 10 ML |
| Approved | 02308495 | AMGEN CANADA INC | VECTIBIX | Human | Yes | Schedule D | 1 | PANITUMUMAB | 200 MG / 10 ML |
| Marketed | 02308509 | AMGEN CANADA INC | VECTIBIX | Human | Yes | Prescription | 1 | PANITUMUMAB | 400 MG / 20 ML |
| Marketed | 02308509 | AMGEN CANADA INC | VECTIBIX | Human | Yes | Schedule D | 1 | PANITUMUMAB | 400 MG / 20 ML |
| Marketed | 02544180 | AMGEN CANADA INC | WEZLANA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02544180 | AMGEN CANADA INC | WEZLANA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02544199 | AMGEN CANADA INC | WEZLANA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
| Marketed | 02544199 | AMGEN CANADA INC | WEZLANA | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
| Marketed | 02544202 | AMGEN CANADA INC | WEZLANA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02544202 | AMGEN CANADA INC | WEZLANA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02544210 | AMGEN CANADA INC | WEZLANA I.V. | Human | Yes | Schedule D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02544210 | AMGEN CANADA INC | WEZLANA I.V. | Human | Yes | Prescription | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02368153 | AMGEN CANADA INC | XGEVA | Human | Yes | Prescription | 1 | DENOSUMAB | 120 MG / 1.7 ML |
| Marketed | 02368153 | AMGEN CANADA INC | XGEVA | Human | Yes | Schedule D | 1 | DENOSUMAB | 120 MG / 1.7 ML |
Application information
Related information
Contact us
Version 4.0.2